期刊文献+

复方苦参注射液联合三维适形调强放疗治疗局部晚期胰腺癌临床观察 被引量:6

Clinical observation of locally advanced pancreatic cancer treated by compound matrine injections combined with three-dimensional conformal intensity modulated radiotherapy
原文传递
导出
摘要 目的 研究复方苦参注射液联合三维适形调强放疗治疗局部晚期胰腺癌的近期临床效果.方法 48例局部晚期初治胰腺癌患者分为三维适形调强放疗加复方苦参组(治疗组)和三维适形调强放疗组(对照组),每组24例.三维适形调强放疗采用95%的等剂量曲线覆盖计划靶区.采用6MVX线照射,2 Gy/次,5次/周,总放疗剂量50 Gy.治疗组治疗前l周给予输注复方苦参注射液20 ml/次,1次/d,21 d为1个周期;对照组单纯行调强放疗.结果 治疗结束后治疗组临床受益反应率为87.5%(21/24),对照组为70.83%(17/24),两组比较差异具有统计学意义(P=0.045).治疗组近期疗效有效率为79.17 %(19/24),对照组为50.00%(12/24),两组比较差异具有统计学意义(P=0.035).血液毒性不良反应中,治疗组白细胞下降发生率为16.67%(4/24),对照组为45.83%(11/24),两组比较差异具有统计学意义(P=0.029).结论复方苦参注射液联合三维适形调强放疗治疗局部晚期胰腺癌效果较好,可缓解疼痛,提高近期疗效,减轻不良反应,改善患者生活质量. Objective To study the recent clinical efficacy of compound matrine injections combined with three-dimensional conformal intensity modulated radiotherapy in the treatment of locally advanced pancreatic cancer. Methods 48 cases of untreated locally advanced pancreatic cancer were randomly divided into treatment group (compound matrine injections combined with three-dimensional cunformal intensity modulated radiotherapy) and control group (three-dimensional conformal intensity modulated radiationtherapy), there were 24 cases in each group. Three-dimensional conformal intensity modulated radiation therapy used 95 % isodose coverage PTV. Using 6 MV X-ray irradiation, 2 Gy/day, 5 times/week, the total radiation dose was 50 Gy/25 times/5 weeks to complete. Treatment group: one week before treatment infusion of compound matrine injections 20 ml/time, l/d, 21-day was one cycle. Control group: simple intensity modulated radiotherapy. Results After treatment, the clinical benefit response rate of the treatment group was 87.5 % (21/24), the control group was 70.83 % (17/24), the difference was statistically significant (P = 0.045). Term efficacy rate of the treatment group was 79.17 % (19/24), the control group was 50.00 % (12/24), the difference was statistically significant (P = 0.035). Adverse reactions were hematologic toxicity, leukopenia occurred in the treatment group was 16.67 % (4/24), but the control group was 45.83 % (11/24), the difference was statistically significant (P = 0.029). Conclusion The effects of compound matrine injections combined with three-dimensional conformal intensity modulated radiotherapy for locally advanced pancreatic cancer are good, they can relieve pain, improve short-tem~ efficacy, reduc side effects, and improve the quality of life.
出处 《肿瘤研究与临床》 CAS 2014年第3期190-192,共3页 Cancer Research and Clinic
关键词 胰腺肿瘤 放射疗法 调强适形 复方苦参注射液 Pancreatic neoplasms Radiotherapy, intensity-modulated Compound matrineinjections
  • 相关文献

参考文献7

二级参考文献24

共引文献80

同被引文献54

  • 1金海国,李忠,张晶,张矛.老年胰腺癌3种放射治疗的疗效对比[J].中国老年学杂志,2014,34(8):2259-2260. 被引量:1
  • 2杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1469
  • 3魏瑞,杨丁懿,姜武忠,等.复方苦参注射液联合放化疗治疗Ⅲ期鼻咽癌的临床观察[J].中华肿瘤杂志,2011,33(5):391-394.
  • 4Sun Q Z, Ma W L, Gao Y, et al. Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound Kushen Injection in hepatocellular carcinoma [J]. Afr J Tradit Complement Altern Med, 2012, 9(2): 178-188.
  • 5Xu W R, Lin H H, Zhang Y, et al. Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway [J]. J Exp Clin Cancer Res, 2011, 30(1): 103-106.
  • 6Cao S M, Liu Z W, Jia W H. Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: A prospective screening study with a 20-year follow-up [J]. PLoS One, 2011, 6(4): 191-195.
  • 7Luo D H, Chen Q Y, Liu H, et al. The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways [J]. J TransI Med, 2013, 11 (8): 203-206.
  • 8Zhang H B, Xia W X, Lu X, et al. A novel statistical prognostic score model that includes serum cxcl5 levels and clinical classification predicts risk of disease progression and survival of nasopharyngeal carcinoma patients [J]. PLoS One, 2013, 8(2): 118-124.
  • 9COX J D, STETZ J, PAJAK T F. Toxicity criteria of the radiationtherapy oncology group (RTOG) and the European organization forresearch and treatment of cancer(EORTC)[J]. Int J Radiat OncolBiol Phys,1995,31(5):1341-1346.
  • 10凌云华,吴洪斌,吴薇,徐红冰,奚菁颖,陈志东,温燕,陶静,陆国椿,陆益,沈敏.119例口服卡培他滨片不良反应分析[J].中国医院用药评价与分析,2008,8(3):224-226. 被引量:21

引证文献6

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部